Results 191 to 200 of about 1,875,087 (345)

Psychiatric and Substance Use Disorders in Individuals with Hepatitis C [PDF]

, 2006
Jennifer M. Loftis, Annette M. Matthews, Péter Hauser   +2 more
openalex   +1 more source

Active Seizures Predict Worse Instrumental Activities of Daily Living in Individuals With Normal Cognition and Dementia

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives Cognitive disorders are common in older persons with seizures (PWS). Cognitive disorders are often associated with impaired Instrumental Activities of Daily Living (IADLs). However, the effects of seizures on IADLs remain unexplored.
Ifrah Zawar, Jaideep Kapur, Meghan M. Mattos, Carol Manning, Syeda Amrah Hashmi, Mark Quigg   +5 more
wiley   +1 more source

Role of Nanomedicine in Transforming Pharmacotherapy for Substance Use Disorder (SUD). [PDF]

Wiley Interdiscip Rev Nanomed Nanobiotechnol
Patne AY, Mohapatra S, Mohapatra SS.
europepmc   +1 more source

Prescribing Benzodiazepines for Patients With Substance Use Disorders

, 2004
Daniel Z. Lieberman
openalex   +2 more sources

A practical system for monitoring the outcomes of substance use disorder patients [PDF]

, 2006
Quyên Q. Tiêt, Hilary F. Byrnes, Paul G. Barnett, John W. Finney   +3 more
openalex   +1 more source

Genetic Diversity and Expanded Phenotypes in Dystonia: Insights From Large‐Scale Exome Sequencing

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Dystonia is one of the most prevalent movement disorders, characterized by significant clinical and etiological heterogeneity. Despite considerable heritability (~25%), the etiology in most patients remains elusive. Moreover, understanding correlations between clinical manifestations and genetic variants has become increasingly ...
Mirja Thomsen, Fabian Ott, Sebastian Loens, Gamze Kilic‐Berkmen, Ai Huey Tan, Shen‐Yang Lim, Ebba Lohmann, Kaja M. Schröder, Lea Ipsen, Lena A. Nothacker, Linn Welzel, Alexandra S. Rudnik, Frauke Hinrichs, Thorsten Odorfer, Kirsten E. Zeuner, Friederike Schumann, Andrea A. Kühn, Simone Zittel, Marius Moeller, Robert Pfister, Christoph Kamm, Anthony E. Lang, Yi Wen Tay, Ana Luísa de Almeida Marcelino, Marie Vidailhet, Emmanuel Roze, Joel S. Perlmutter, Jeanne S. Feuerstein, Victor S. C. Fung, Florence Chang, Richard L. Barbano, Steven Bellows, Aparna A. Wagle Shukla, Alberto J. Espay, Mark S. LeDoux, Brian D. Berman, Stephen Reich, Andres Deik, Andre Franke, Michael Wittig, Sören Franzenburg, Jens Volkmann, Norbert Brüggemann, H. A. Jinnah, Tobias Bäumer, Christine Klein, Hauke Busch, Katja Lohmann   +47 more
wiley   +1 more source

Quality indicators for substance use disorder care: a scoping review protocol. [PDF]

BMJ Open
Richards TD, Kirkham J, Lorenzetti D, Anderson J, Bahji A, Allami Y, Crockford D, Dyson MP, Ghosh SM, Hodgins D, Messier G, Vik S, Seitz DP.   +12 more
europepmc   +1 more source

Treating complicated grief and substance use disorders: A pilot study [PDF]

, 2006
Allan Zuckoff, Katherine Shear, Ellen Frank, Dennis C. Daley, Karen Seligman, Russell Silowash   +5 more
openalex   +1 more source

Stage‐Dependent Inhibitory Connectivity in Striatal‐Motor Circuit in Huntington's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Elucidating dysfunctional connectivity patterns among key brain regions in Huntington's disease (HD) underlying progression may have implications for developing treatment and therapeutic evaluation. Objective Explore the relationship between abnormal spontaneous resting‐state activity and atrophy in HD‐specific brain regions and ...
Yinghua Jing, Imis Dogan, Rena Theda Overbeck, Kathrin Reetz, Sandro Romanzetti   +4 more
wiley   +1 more source

Cell-type specific epigenetic and transcriptional mechanisms in substance use disorder. [PDF]

Front Cell Neurosci
Wang B, Wang J, Beacher NJ, Lin DT, Zhang Y.   +4 more
europepmc   +1 more source